Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | ANPEP | P15144 | 5/20 | 0.40 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.40 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 2/20 | 0.38 |
| ▸ | METAP1 | P53582 | 2/20 | 0.38 |
| ▸ | PPID | Q08752 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133092 | 1.00 | SLC7A5 (0.54) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| SCHEMBL196637 | 1.00 | SLC7A5 (0.54) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10887590 | 0.98 | SLC7A5 (0.52) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL818970 | 0.98 | SLC7A5 (0.52) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL133091 | 0.98 | SLC7A5 (0.52) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6846663 | 0.96 | SLC7A5 (0.50) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| SCHEMBL10866196 | 0.94 | SLC7A5 (0.48) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| Phosphoric Acid SCHEMBL28734810 | 0.92 | SLC7A5 (0.47) | SLC7A5ALOX15SLC1A3SLC1A2ANPEP | |
| Sulfuric Acid SCHEMBL28734782 | 0.92 | SLC7A5 (0.47) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 | |
| SCHEMBL28856635 | 0.90 | SLC7A5 (0.45) | SLC7A5ALOX15SLC1A3SLC1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119667035-A | Method for rapidly detecting chiral substances in white spirit and fermented grains and application | 宜宾五粮液股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119667035-A | Method for rapidly detecting chiral substances in white spirit and fermented grains and application | 宜宾五粮液股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-117794580-A | Polypeptide coupling medicine | 肿瘤多肽有限公司 | 2024-03-29 | — | — | CN | disclosed |
| WO-2022263679-A1 | PEPTIDE DRUG CONJUGATES | ONCOPEPTIDES AB (SE) | 2022-12-22 | — | — | WO | disclosed |
| EP-2852603-B1 | D-AMINO ACID COMPOUNDS FOR LIVER DISEASE | IDENIX PHARMACEUTICALS LLC (US) | 2021-05-12 | — | — | EP | disclosed |
| US-20190292149-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | PURDUE PHARMA LP (US) | 2019-09-26 | — | — | US | disclosed |
| US-10202344-B2 | Aryl substituted indoles and the use thereof | PURDUE PHARMA L.P. (US) | 2019-02-12 | — | — | US | disclosed |
| EP-2906579-B1 | 2'-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION | IDENIX PHARMACEUTICALS LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| US-20180022699-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | PURDUE PHARMA L.P. | 2018-01-25 | — | — | US | disclosed |
| US-20180022699-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | PURDUE PHARMA L.P. | 2018-01-25 | — | — | US | disclosed |
| EP-2889293-A1 | THIAZINE AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China (CN) | 2015-07-01 | — | — | EP | disclosed |
| US-20130296281-A1 | Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels | PURDUE PHARMA L.P. (US) | 2013-11-07 | — | — | US | disclosed |
| CN-101248184-B | Process for production of optically active (S or R)-a-amino acid or optically active (S or R)-a -amino acid ester | UBE INDUSTRIES | 2013-01-16 | — | — | CN | disclosed |
| US-8143052-B2 | Process for preparing optically active (S or R)-α amino acid and (R or S)-α amino acid ester in one phase organic reaction medium | UBE INDUSTRIES, LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| CN-101248184-A | Process for production of optically active (S or R)-a-amino acid or optically active (S or R)-a -amino acid ester | UBE INDUSTRIES (JP) | 2008-08-20 | — | — | CN | disclosed |
| US-20080153801-A1 | Benzoxazepine compounds, their production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2008-06-26 | — | — | US | disclosed |
| US-4616002-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-10-07 | — | — | US | disclosed |
| US-4572894-A | USING AMINOACYL-TRNA SYNTHETASE AS CONDENSING AGENT | Imahori, Kazutomo (JP) | 1986-02-25 | — | — | US | disclosed |
| EP-0086053-B1 | PROCESS FOR SYNTHESIZING PEPTIDES OR PEPTIDE DERIVATIVES | Imahori, Kazutomo (JP) | 1986-01-02 | — | — | EP | disclosed |
| EP-0086053-A1 | Process for synthesizing peptides or peptide derivatives | Imahori, Kazutomo (JP) | 1983-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296281-A1 | Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels | SCN5A, TRPV1, TRPV5 | SLC7A5 301/4885ALOX15 925/4885SLC1A3 382/4885 |
| US-20190292149-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | TRPC5, TRPV5, TRPV1 | SLC7A5 242/4885ALOX15 607/4885SLC1A3 465/4885 |
| US-20180022699-A1 | ARYL SUBSTITUTED INDOLES AND THE USE THEREOF | TRPC5, TRPV5, TRPV1 | SLC7A5 242/4885ALOX15 607/4885SLC1A3 465/4885 |
| US-10202344-B2 | Aryl substituted indoles and the use thereof | TRPC5, TRPV5, TRPV1 | SLC7A5 242/4885ALOX15 607/4885SLC1A3 465/4885 |
| US-20080153801-A1 | Benzoxazepine compounds, their production and use | CETP, PCSK9, LPL | SLC7A5 2699/4885ALOX15 108/4885SLC1A3 3684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.